Logo image
Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement
Journal article   Open access   Peer reviewed

Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement

Kirsten Bibbins-Domingo, David C Grossman, Susan J Curry, Karina W Davidson, John W Epling Jr, Francisco A R García, Jessica Herzstein, Alex R Kemper, Alex H Krist, Ann E Kurth, …
JAMA : the journal of the American Medical Association, Vol.317(4), pp.407-414
01/24/2017
DOI: 10.1001/jama.2016.20325
PMID: 28118461
url
https://doi.org/10.1001/jama.2016.20325View
Published (Version of record) Open Access

Abstract

Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5% for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).
Adult Advisory Committees Asymptomatic Diseases - epidemiology Asymptomatic Diseases - therapy Decision Making Early Diagnosis Humans Practice Guidelines as Topic Prevalence Primary Health Care Risk Assessment Sleep Apnea, Obstructive - diagnosis Sleep Apnea, Obstructive - epidemiology Sleep Apnea, Obstructive - therapy Surveys and Questionnaires United States - epidemiology

Details

Logo image